Schedule 13D - Activist Investments
NASDAQ
Jin Medical International Ltd. reports a significant dilution in beneficial ownership percentage for key stakeholders following a substantial share issuance.
Capital raise
NASDAQ
Jin Medical International Ltd. announces a strategic share restructuring involving key shareholder Erqi Wang to maintain voting control amidst a recapitalization and acquisition.